InvestSMART

Alcidion Group Limited (ASX:ALC)

ALERT: Price-sensitive ASX Announcement for ALC
Current share price for ALC : $0.092 -0.018 (-16.36%)+
Announcement
Release
25 May 2026 8:21AM
Price at Release
$0.110
Full Release
download
Summary
Alcidion Group Limited has entered into a 7-year agreement with University Hospitals Sussex NHS Foundation Trust to implement their Miya Precision Electronic Patient Record platform, valued at $35 million with an option to extend to 10 years, potentially reaching $49 million. Implementation is set to commence immediately, targeting a phase one go-live in June 2027. The contract is expected to yield $8.5 million in revenue for Alcidion in FY26. This initiative aims to enhance patient care and operational efficiency through a unified digital platform.
Key Points
  • Alcidion Group Limited signed a 7-year contract with University Hospitals Sussex NHS Foundation Trust (UHSussex).
  • The contract is for deploying the Miya Precision Electronic Patient Record (EPR) platform.
  • The total contract value is approximately $35 million for an initial 7-year term, with rights to extend to 10 years, potentially increasing the value to $49 million.
  • Implementation will begin immediately, with a phase one go-live target date of June 2027.
  • Alcidion is expected to recognize approximately $8.5 million in revenue in FY26 from this contract.
  • The Miya Precision EPR platform will include modules like Miya Observations, Assessments, and Patientrack.
  • This marks the third EPR platform contract secured by Alcidion in the UK.
  • UHSussex aims to integrate a single digital platform to improve patient care and support regional integration and operational efficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.